paris

SimCorp to transform private market investing with SimCorp Alternatives

Highlights: SimCorp launches SimCorp Alternatives, a comprehensive offering designed to serve the needs of all alternative investment firms. It builds…

1 day ago

Ipsen – July 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…

1 week ago

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

August 21, 2025 01:30 ET  | Source: NICOX SA Press Release Nicox Announces Positive Results from the NCX 470 Phase…

2 weeks ago

Introducing Miutine, the new irreverent, fragrance by Miu Miu

PARIS, Aug. 19, 2025 /PRNewswire/ -- Miu Miu unveils Miutine, the new feminine fragrance, capturing the ultimate essence of the…

2 weeks ago

HR Path Strengthens Global Presence with Strategic Acquisition of RKM Consulting in Australia

PARIS, Aug. 14, 2025 /PRNewswire/ -- HR Path, a global leader in HR consulting and HRIS solutions, is proud to…

3 weeks ago

HR Path Strengthens Global Presence with Strategic Acquisition of PredictiveHR

PARIS, Aug. 6, 2025 /PRNewswire/ -- HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce…

4 weeks ago

Safeguarding the Games: Welfare Officers play vital role at Paris 2024

07 August 2025 - On the occasion of Safe Sport Day, the IOC highlights some of the new measures put in place during…

4 weeks ago

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

4 weeks ago

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information

Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

4 weeks ago

Atos – Half-year 2025 results on track. Full Year 2025 targets confirmed

Press Release Half-year 2025 results on track Full Year 2025 targets confirmed Significant progress in the execution of the Genesis…

1 month ago